1.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 54 and under
Sponsor: Other
Protocol IDs: 0107M05202, MT2001-02, NCT00176930
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: SCT 0307, NCT00619879
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 4 to 21
Sponsor: NCI
Protocol IDs: NCI-01-C-0125F, NCT00020592
|
|
4.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 70 and under
Sponsor: Other
Protocol IDs: H8713, NCT00058825
|
|
5.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Under 75
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: FHCRC-1825.00, 5605, SUPERGEN-FHCRC-1825.00, NCT00096161
|
|
6.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: 9911M24961, MT1999-20, 1999LS073, NCT00167219
|
|
7.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Under 55
Sponsor: NCI
Protocol IDs: MSKCC-06125, NCT00423514
|
|
8.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDX-009, NCT00481871
|
|
9.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 70 and under
Sponsor: Other
Protocol IDs: BCM-H-19386, BCM-FAB, H 19386, NCT00625144
|
|
10.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Under 100
Sponsor: Other
Protocol IDs: BCM-H-12472, H 12472, BCM-ACHE, NCT00056966
|
|
11.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Juvenile
Sponsor: NCI
Protocol IDs: UMN-1999LS032, UMN-1999LS032, UMN-MT1999-08, NCT00609739
|
|
12.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 0 to 55
Sponsor: Other
Protocol IDs: 8717, NCT00673114
|
|
13.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 65 and under
Sponsor: Other
Protocol IDs: J0844, JHM IRB # NA_00017193, NCT00809276
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 8 to 80
Sponsor: NHLBI
Protocol IDs: NHLBI-99-H-0050, NCT00003838
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 65 and under
Sponsor: NCI
Protocol IDs: CPMC-IRB-AAAA5571, CPMC-CAMP-016, NCI-G00-1891, NCT00008216
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 55 and under
Sponsor: NCI
Protocol IDs: CASE-CWRU-1Y00, NCT00054327, CASE-1Y00
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: ID02-407, NCT00067002
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: PSCI-2003-232, NCT00084695
|
|
19.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: Under 75
Sponsor: NCI
Protocol IDs: FHCRC-1898.00, 5788, NCT00089011
|
|
20.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: FHCRC-1938.00, 5887, NCT00105001
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Under 75
Sponsor: NCI
Protocol IDs: FHCRC-1959.00, 5952, NCT00118352
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 45 and under
Sponsor: NCI
Protocol IDs: UMN-2005LS043, UMN-BMT-MT2005-10, UMN-MT2005-10, UMN-0507M71475, NCT00309842
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Older patients
Sponsor: NCI, Other
Protocol IDs: BMT124, 75117, BMT124, NCT00185692, NCT00185692
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: BMT 0300 Mini, NCT00179764
|
|
25.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Under 70
Sponsor: NCI
Protocol IDs: UMN-2005LS036, UMN-MT-2005-02, UMN-0507M70121, NCT00305682
|
